© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
203272 |
As an accredited Methyl 2-Amino-5-Bromothiazole-4-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive Methyl 2-Amino-5-Bromothiazole-4-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Methyl 2-Amino-5-Bromothiazole-4-Carboxylate gets noticed by chemists who care about pathways that other materials simply can’t unlock. With the formula C6H5BrN2O2S, this compound stands apart through the precise integration of a bromine atom at the 5-position and a methyl ester at the 4-carboxylate, making it a unique key for novel molecules. Researchers who work in the thiazole field often talk about how frustrating it can be to find clean, reliable building blocks that consistently deliver results in medicinal chemistry, agrochemical development, and materials science. In each of my research collaborations, accuracy often makes or breaks a synthetic sequence. Every small difference in atomic arrangement brings a ripple effect in robustness, reactivity, and the unexpected twists that can change a project’s direction.
The value you draw from a compound like this depends on more than purity. It’s about how the structure combines several features that are rare to find together. The ester group brings increased versatility, supporting not only condensation routes but also facilitating functional group transformations you might need later in a synthetic pathway. The aminothiazole core draws special attention in pharmaceutical design for its electron-rich profile, providing a foundation for bioactive molecules that interact with a range of targets from enzymes to kinase receptors. The presence of bromine at the fifth position turns the compound into a superb handle for Suzuki-Miyaura, Buchwald-Hartwig, and other cross-coupling reactions. Experienced synthetic chemists frequently nod to the importance of these moieties—every substituent opens new pathways or closes off complications. I’ve personally found that skipping the hunt for exotic protecting groups by using well-placed halogens saves a lot of lab time.
Many researchers have faced the issue of structural isomers or impure thiazole products creating confusion and waste. Many commercial stocks feature 2-aminothiazole or brominated variants that lack controlled placement of the carboxylate ester. One batch of generic aminothiazole will never produce the same results as a model with both bromine and the methyl ester in locked-in positions. Friends in both pharmaceutical and agricultural synthesis circles often point out that this difference shows up as cleaner chromatograms and easier separations. The downstream difference: fewer surprises during scale-up, fewer headaches in analytical validation, and fewer dead-ends in late-stage synthesis.
Any drug chemist who spends time with related thiazoles knows the headaches that come with slow, messy substitutions or unpredictable binding profiles. Structure-activity relationships (SAR) change drastically when the thiazole ring is carefully decorated as in this compound. The amino group effects hydrogen bonding, altering both solubility and how well the molecule embeds itself into biological sites. Bromine, a heavy halogen, adds bulk and influences binding affinity with proteins. Subtle choices, like swapping a hydrogen for bromine or switching an acid for a methyl ester, drive everything from metabolism rate to oral bioavailability. The methyl ester group doesn’t just help with reaction chemistry—the added lipophilicity often improves absorption, a lesson that got drilled into me after running late-stage in vivo studies using closely related intermediates.
Successful research hinges on reliability. From long days in the lab, I’ve learned that the stated purity in the data sheet doesn’t always match the performance in practice. Still, typical specifications matter because even small impurities derail downstream steps. Analytical HPLC readings frequently indicate purities above 97% for well-prepared batches. Melting points, usually hovering near the product’s characteristic range, provide insight into both stability and ease of work-up. Moisture content checks and spectral data ensure the absence of water and oxidation byproducts, issues that run rampant in cheaper generics. Researchers who’ve found themselves purging columns again and again just to meet specification will appreciate a material that gets close to theoretical values right from the first run.
What sets Methyl 2-Amino-5-Bromothiazole-4-Carboxylate apart lies in what professionals often overlook. The simultaneous inclusion of a methyl ester, amino group, and specifically positioned bromine is rare on the market, partly because the synthesis demands strict controls at every stage. Thiazoles carrying less functionalization, or ones that swap out bromine for chlorine or iodine, don’t allow the same synthetic flexibility. Using this model, I’ve been able to design routes that open up new compound libraries or close gaps left unfinished by less tuned starting materials. This specificity is not just a matter of pride for suppliers—it’s the difference between novel analogue discovery and dead ends in research grants.
The reach of this molecule stretches further than routine research. Medicinal chemists looking to design kinase inhibitors, antibiotics, or anti-inflammatory agents know how crucial a responsive, multi-functional thiazole intermediate can be. Drug development teams prize aromatic amines and halogenated scaffolds when mapping out SAR, and computer-aided design tools often select such substituted thiazole rings for docking studies. My experience with high-throughput screening campaigns confirms that analogues built from this compound show improved hit rates in enzyme interaction pools. It makes sense—by stacking both an electron-donating amino group and the reactive bromine, the thiazole maintains just enough balance between activity and stability to give new candidates a strong start.
It’s tempting to think all thiazole derivatives bring similar performance. Generic 2-aminothiazoles without bromine lack the chemistry needed for cross-coupling diversity. Those with free carboxylic acid groups limit processability, especially in environments requiring esterification or transesterification. Esters with less activating groups often limit further diversification, choking off modifications at critical development stages. Several times, I’ve run side-by-side experiments using these variants—only the fully functionalized methyl 2-amino-5-bromothiazole-4-carboxylate supported efficient, clean C-C or C-N bond formation using mild conditions. For anyone scaling synthesis from milligrams to grams, this makes the difference between iterative success and bottlenecks.
Multi-step syntheses often hit snags on intermediate complexity or decomposition. In my independent routes and collaborative projects, including those at academic and industry labs, we’ve navigated transformability with this compound that frustrates simpler analogues. The electron-rich amino group tolerates a range of acylations, sulfonations, and condensations without triggering side-products that plague less robust heterocycles. Bromine substitution enables late-stage diversification, letting teams introduce aryl or alkyl chains only when every other key transformation proves robust. Methyl ester protection cuts down on base-catalyzed hydrolysis—a feature that saved one of my own SAR campaigns from endless repurification cycles. Details like these reduce the risk of a stalled project and move teams closer to an actionable lead compound.
Once a route shows promise, reliable sourcing underpins the hopes of any research group. Scaling laboratory breakthroughs to larger, more practical runs—sometimes even pilot plant-scale—often reveals limits in starting material quality. I’ve watched many pilot runs falter due to unexpected melting point shifts, subtle water incorporation, or undetected byproducts lurking in less regulated supply chains. Teams working on clinical candidates or regulatory submissions hold steady access to this high-quality model in high regard. Avoiding batch variability cuts down on rejection rates, wasted reagents, and extra analytical work. From past projects, I know the assurance of batch-to-batch consistency matters just as much as core analytical specs when project timelines tighten.
Research priorities shift toward environmental and workplace safety every year. Though thiazole derivatives bring strength to the researcher’s toolkit, proper precautions always deserve attention. Handling protocols for Methyl 2-Amino-5-Bromothiazole-4-Carboxylate closely resemble those for other aromatic amino esters: use in a ventilated hood, avoid skin and eye contact, and store away from heat and moisture. Conscious suppliers employ greener synthesis routes, sometimes reducing byproducts and embracing solvent recovery. While data about this exact compound’s environmental footprint remains under study, preference continues for sources that openly report their production methods. In my view, knowing where and how a chemical is made not only boosts confidence in supply but aligns benchwork with wider sustainability goals embraced by leading institutions.
Smooth handling doesn't come from data sheets alone; it grows from hands-on experience. Weighing portions of this compound, I’ve found the fine, off-white powder flows without clumping, and it dissolves reliably in common solvents like DMSO, DMF, or ethanol—giving flexibility whether you’re prepping solutions for chromatography or scaling up a reaction flask. Many synthetic schemes I’ve built relied on this kind of solubility; running reactions without constant stirring or heating simplifies both setup and work-up. Precise weighing and containment in amber glass vials ensure minimal photo-decomposition and moisture pickup. Having lost a few samples to humidity in the past, I now emphasize sealed storage and rapid bench handling to all newcomers in the lab.
Where does this compound truly shine? Medicinal chemists, especially those leading exploratory projects, use thiazole derivatives to probe chemical space not covered by simpler heterocycles. Brominated thiazoles with ester protection underpin fragment-based drug design programs and are frequent starting points in novel anti-infective campaigns. The agricultural sector often explores these models as fungicide, herbicide, or insecticide intermediates—structure provides a platform that, with just a tweak, aligns with a family of crop protection agents. Material scientists have even explored related thiazoles as functionalized ligands in metal-organic frameworks, sensing applications, and electronics. Each field wants flexibility and reliability; my colleagues staying close to application development frequently rely on this compound, not because it's ‘one-size-fits-all’, but because its modularity unlocks further design freedom.
Purity means more than just an HPLC readout. Consistent color and melting profiles have saved me hours during preparative purification, reducing the risk of rejecting a synthesized analogue further downstream. Fine product with repeatable, clean melting properties not only reassures, but streamlines handoff to analytical teams. Squinting over inconsistent crystals or worrying about residue sticking to the glassware during evaporation often signals an underlying issue. Feedback from longstanding collaborators underscores this point—successful projects nearly always document how early reliability translates to faster lead optimization.
Anyone navigating complex supply chains knows sourcing high-quality thiazole intermediates poses ongoing challenges. Market fluctuation, import restrictions, or supply shortages can disrupt work at pivotal stages. Teams that commit to open communication, vetting of supplier certifications, and insistence on clear batch analytics fare better. I’ve watched project managers compensate for hiccups by ordering multiple lots or batch reserving for planned scale-ups; proactive planning and direct dialogue with suppliers ensures uninterrupted workflows. Pushing for transparency on COAs, synthesis routes, and impurity profiles makes the difference in both smaller academic groups and larger industrial settings.
Educating trainees and new colleagues about the capabilities of methyl 2-amino-5-bromothiazole-4-carboxylate forms a core part of method development. I’ve seen growth in adoption of this model as software predictions and AI-based SAR analyses reveal the unique chemical space it covers. Limiting synthetic options to widely available, simple thiazoles restricts creativity—this highly functionalized derivative encourages broader, more ambitious synthetic and medicinal chemistry. Research teams that adjust their screening sets and synthesis plans toward value-added thiazoles find hit rates climb and compound variety expands. The intersection of molecular diversity and practical usability improves output across all research stages.
Innovation often tracks how easily new chemical space is explored. New classes of kinase inhibitors, anti-infective drugs, and advanced agricultural agents depend on ready access to starting materials with the right pattern of substitution. I watched as a partnering group built their lead candidate—in just a few steps—starting with this model compound as the scaffold, crediting its advanced substitution pattern with sparking success in biological screens. As AI-powered discovery tools predict more diverse binding sites and synthetic niches, research will need flexible, robust substrates like methyl 2-amino-5-bromothiazole-4-carboxylate even more. Any research lab aiming to stay ahead of the curve needs these core tools today, not tomorrow.
Pharmaceutical and agrochemical discovery shouldn’t choke on supply or underwhelming starting points. Regulation grows tighter; analytical thresholds climb. Quality assurance teams in both academic and private settings keep up by logging data from each batch and keeping tabs on full spectral confirmation—IR, NMR, and MS all checked and cross-verified against trusted literature sources. In collaborative projects, clear tracking links structure, batch, and test results to outcomes, building robust documentation for publications and patents. Open sourcing of analytical methods proves crucial to troubleshooting, especially as research groups share compounds across borders and disciplines. Discipline in documentation pays dividends by streamlining both publication and regulatory submission.
Research teams always push for process improvements: greater yields, greener synthesis, and smoother downstream purification. I’ve participated in brainstorming sessions where folks in process chemistry look for new catalyst strategies or solvent swaps that match industrial scaleups without raising costs or lowering quality. Future work will look to solventless routes, biocatalytic alternatives, and AI-predicted pathways as they become practical. In the near term, wider education on the capabilities this molecule offers, plus better access to small and mid-scale lots, will support more innovation across the spectrum of synthetic and medicinal chemistry.
The story of methyl 2-amino-5-bromothiazole-4-carboxylate highlights how thoughtful molecular design and careful characterization empower modern chemistry. Researchers across pharma, agroscience, and materials increasingly face demands for creativity, speed, and reproducible results. Having a building block like this available—one that consistently performs and adapts to many routes—provides much-needed reliability and sets a strong foundation for advanced molecular design. It’s more than just a reagent; it’s a statement that serious research values precision, flexibility, and progress shaped by the experience of scientists at the bench.
